fluorodeoxyglucose f18 has been researched along with Lymphangitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Su, M; Wang, Y | 1 |
| Digumarthy, SR; Kalra, MK; Prakash, P; Sharma, A; Shepard, JA | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Lymphangitis
| Article | Year |
|---|---|
Pulmonary lymphangitic carcinomatosis without concurrent liver metastasis from colon cancer detected using 18F-FDG PET/CT: A case report.
Topics: Aged; Carcinoma; Colonic Neoplasms; Fluorodeoxyglucose F18; Humans; Lung; Lung Neoplasms; Lymphangitis; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2019 |
FDG PET/CT in assessment of pulmonary lymphangitic carcinomatosis.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Lung Neoplasms; Lymphangitis; Male; Middle Aged; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity | 2010 |